<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Ankylosing_spondylitis</id>
	<title>Ankylosing spondylitis - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Ankylosing_spondylitis"/>
	<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Ankylosing_spondylitis&amp;action=history"/>
	<updated>2026-05-13T00:01:20Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://idwiki.org/index.php?title=Ankylosing_spondylitis&amp;diff=4932&amp;oldid=prev</id>
		<title>Aidan: Text replacement - &quot;Clinical Presentation&quot; to &quot;Clinical Manifestations&quot;</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Ankylosing_spondylitis&amp;diff=4932&amp;oldid=prev"/>
		<updated>2020-07-14T23:43:29Z</updated>

		<summary type="html">&lt;p&gt;Text replacement - &amp;quot;Clinical Presentation&amp;quot; to &amp;quot;Clinical Manifestations&amp;quot;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 23:43, 14 July 2020&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 33:&lt;/td&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 33:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**** Psoriasis&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**** Psoriasis&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Clinical &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Presentation&lt;/del&gt; ==&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Clinical &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Manifestations&lt;/ins&gt; ==&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Ache and tenderness of lumbar or gluteal regions&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Ache and tenderness of lumbar or gluteal regions&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;

&lt;!-- diff cache key site7_mediawiki:diff:1.41:old-4088:rev-4932:wikidiff2=table:1.13.0:bc2a06be --&gt;
&lt;/table&gt;</summary>
		<author><name>Aidan</name></author>
	</entry>
	<entry>
		<id>https://idwiki.org/index.php?title=Ankylosing_spondylitis&amp;diff=4088&amp;oldid=prev</id>
		<title>Maintenance script: Imported from text file</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Ankylosing_spondylitis&amp;diff=4088&amp;oldid=prev"/>
		<updated>2020-07-04T01:17:23Z</updated>

		<summary type="html">&lt;p&gt;Imported from text file&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Definition ==&lt;br /&gt;
&lt;br /&gt;
* An axial seronegative spondyloarthritis characterized by sacroiliitis and progressive spinal disease&lt;br /&gt;
&lt;br /&gt;
== Risk Factors ==&lt;br /&gt;
&lt;br /&gt;
* Age 20s to 30s&lt;br /&gt;
* Male to female ratio of 2:1 to 3:1&lt;br /&gt;
&lt;br /&gt;
== Diagnostic Criteria (ASAS) ==&lt;br /&gt;
&lt;br /&gt;
* ≥3 months of back pain, and&lt;br /&gt;
* Onset ≤45 years, and&lt;br /&gt;
* Either of:&lt;br /&gt;
** Sacroiliitis on imaging and 1 or more features of spondyloarthritis&lt;br /&gt;
** HLA-B27 positive and 2 or more features of spondyloarthritis&lt;br /&gt;
* Where&lt;br /&gt;
** Sacroiliitis on imaging means either:&lt;br /&gt;
*** Definite evidence based on modeified NY criteria&lt;br /&gt;
*** Active inflammation on MRI&lt;br /&gt;
** Spondyloarthritis features are:&lt;br /&gt;
*** Inflammatory back pain&lt;br /&gt;
*** Response to NSAIDs&lt;br /&gt;
*** Family history of spondyloarthritis&lt;br /&gt;
*** HLA-B27 positive&lt;br /&gt;
*** Elevated CRP&lt;br /&gt;
*** Extra-spinal manifestations&lt;br /&gt;
**** Arthritis&lt;br /&gt;
**** Enthesitis&lt;br /&gt;
**** Uveitis&lt;br /&gt;
**** Dactylitis&lt;br /&gt;
**** Inflammatory bowel disease&lt;br /&gt;
**** Psoriasis&lt;br /&gt;
&lt;br /&gt;
== Clinical Presentation ==&lt;br /&gt;
&lt;br /&gt;
* Ache and tenderness of lumbar or gluteal regions&lt;br /&gt;
* Hip arthritis in 30%, shoulder arthritis in less&lt;br /&gt;
* Bony tenderness of costosternal junctions, spinous processes, iliac crests, greater trochan- ters, ischial tuberosities, tibial tubercles, and heels&lt;br /&gt;
* Peripheral arthritis in 30% of patients, usually asymmetric&lt;br /&gt;
* Sequelae&lt;br /&gt;
** Acute anterior uveitis in 40%&lt;br /&gt;
*** Unilateral painful, teary eye with photophobia&lt;br /&gt;
** Aortic insufficiency (early)&lt;br /&gt;
** Third-degree heart block&lt;br /&gt;
** Cauda equina syndrome and upper pulmonary lobe fibrosis (rare, late)&lt;br /&gt;
** Retroperitoneal fibrosis (rare)&lt;br /&gt;
&lt;br /&gt;
=== Physical exam ===&lt;br /&gt;
&lt;br /&gt;
* Modified Schober test&lt;br /&gt;
** Marks made on the spine at lumbosacral junction (line between the PSISs) and 10 cm above&lt;br /&gt;
** Maximal forward flexion with knees straight&lt;br /&gt;
** Normal ≥5cm, restricted &amp;amp;lt;4cm&lt;br /&gt;
&lt;br /&gt;
=== BASDAI ===&lt;br /&gt;
&lt;br /&gt;
* Disease activity measure&lt;br /&gt;
&lt;br /&gt;
== Investigations ==&lt;br /&gt;
&lt;br /&gt;
* Labs&lt;br /&gt;
** HLA-B27 helpful but neither sufficient nor necessary&lt;br /&gt;
*** 90% of ank spon patients have HLA-B27&lt;br /&gt;
** CRP, elevated&lt;br /&gt;
* Imaging&lt;br /&gt;
** X-ray of the SI joints&lt;br /&gt;
** If x-ray negative but suspicion high, consider MRI&lt;br /&gt;
&lt;br /&gt;
== Management ==&lt;br /&gt;
&lt;br /&gt;
* All patients should participate in active, land-based physical therapy&lt;br /&gt;
* First-line: NSAIDs for a two-week trial&lt;br /&gt;
** Naproxen 500mg PO BID&lt;br /&gt;
** Meloxicam 7.5mg PO BID&lt;br /&gt;
* Second-line, if fails two NSAIDs: biologics&lt;br /&gt;
** Specifically, TNF-alpha inhibitors&lt;br /&gt;
** Etanercept&lt;br /&gt;
* DMARDs &amp;#039;&amp;#039;NOT&amp;#039;&amp;#039; helpful (i.e. methotrexate, sulfasalazine)&lt;br /&gt;
&lt;br /&gt;
[[Category:Rheumatology]]&lt;/div&gt;</summary>
		<author><name>Maintenance script</name></author>
	</entry>
</feed>